Tekla Life Sciences Investors

NYSE:HQL

Asset Management

Financial Services
$19.27 +0.62%

+$0.11 today

Market cap
$585.96M
Beta
0.73
P/E (TTM)
2.8
EPS (TTM)
$6.52
Dividend yield
11.35%
52W Low $12.34High $18.46

Volume 0.12M

Average 0.11M

HQL Total Current Assets

All assets expected to be converted to cash or used up within one year.

Tekla Life Sciences InvestorsNYSE: HQL

Total Current Assets · Q2 FY2026 · quarter ended Mar 2026

Total current assets rises 4903.9% from a year ago

Total current assets stood at $2.13M at the end of Q2 FY2026, up 4903.9% from a year earlier. Over 3 fiscal years it compounded at +26.1% a year.

Context

  • Total current assets amounted to 0.4% of total assets at the end of Q2 FY2026, up 0.4 pp from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.

What to watch

Whether total current assets keeps rising in the next quarterly balance sheet after a +4903.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.13M— QoQ
Last fiscal yearSep 2025
$1.25M+344.8% YoY
Year agoMar 2025
$42.54K+4903.9% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4903.9%——
1 year+344.8%——
3-year CAGR+26.1%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
1.25M USD
Year-over-year change
+344.8%
4-year CAGR
+71.5%

Total Current Assets vs competitors

How HQL compares with its peers on the latest reported figures

  • HQL's Mar 2026 total current assets of $2.13M is the lowest of the 10 companies compared; the peer median is $80.97M.
  • Its year-over-year change of +4903.9% is the 2nd highest of 10, against a peer median of +100.2%.
  • Total current assets amounts to 0.4% of total assets for HQL, versus a peer median of 6.9%.
HQL Competitors Peer median
Total Current Assets for HQL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PNNTPennantPark Investment CorporationMar 2026$19.73B +44560.3%-15.4%1.6%
CIONCION Investment CorporationMar 2026$139.59M +181.3%+11.5%7.6%
TCPCBlackRock TCP Capital Corp.Mar 2026$115.63M -6.1%-8.0%7.7%
ECCEagle Point Credit Company Inc.Dec 2025$96.7M +129.0%-20.0%6.9%
SORSource Capital, Inc.Dec 2025$80.97M +1715.2%+166.5%20.1%
CCAPCrescent Capital BDC, Inc.Mar 2026$77.61M +100.2%-47.7%4.8%
MCIBarings Corporate InvestorsDec 2025$32.12M +17.7%+19.8%7.4%
GAINGladstone Investment CorporationMar 2026$7.96M -34.3%-6.1%0.6%
GLADGladstone Capital CorporationMar 2026$3.39M -59.8%+75.4%0.4%
HQLTekla Life Sciences InvestorsMar 2026$2.13M +4903.9%+26.1%0.4%
Peer median (excluding HQL) $80.97M+100.2%-6.1%6.9%

Competitors are the stored peer set for HQL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents990445477175.54K
Short-term Investments0015.24M17.23M0
Net Receivables150.34K623.47K5.04M231.11K1.14M
Inventory00000
Other Current Assets(32.97K)(25.18K)08.97K0
Total Current Assets144.66K623.92K5.05M281.61K1.25M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments534.01M414.08M397.53M460.3M505.7M
Tax Assets00000
Other Non-current Assets534.01M414.7M402.57M13.9M514.13M
Total Non-current Assets534.01M414.08M397.53M474.2M514.13M
Total Assets534.19M414.73M402.6M460.58M515.38M
Account Payables150.34K5.1M01.79K720.9K
Short-term Debt10.04M11.09M000
Tax Payables00000
Deferred Revenue05.09M000
Other Current Liabilities(8M)(16.18M)050.81K0
Total Current Liabilities10.75M5.1M0888.61K720.9K
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities10.75M11.72M666.96K886.82K1.01M
Total Non-current Liabilities10.75M11.72M666.96K886.82K1.01M
Total Liabilities10.75M16.82M666.96K888.61K1.73M
Common Stock246.68K256.8K267.91K280.61K295.99K
Retained Earnings150.7M9.55M(1.48M)44.13M77.6M
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity523.44M397.9M401.93M459.69M513.66M
Total Debt1.34M11.09M000
Net Debt1.34M10.65K(477)(1)(75.54K)

Tekla Life Sciences Investors

NYSE:HQL

Intrinsic Alpha fair value

Locked

Current Price

$19.27

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.